KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Long-Term Deferred Tax (2016 - 2020)

Emergent BioSolutions' Long-Term Deferred Tax history spans 11 years, with the latest figure at $17.6 million for Q1 2020.

  • For Q1 2020, Long-Term Deferred Tax changed N/A year-over-year to $17.6 million; the TTM value through Mar 2020 reached $17.6 million, changed N/A, while the annual FY2019 figure was $13.4 million, 0.0% changed from the prior year.
  • Long-Term Deferred Tax reached $17.6 million in Q1 2020 per EBS's latest filing, up from $13.4 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $18.2 million in Q2 2016 to a low of $2.8 million in Q4 2017.
  • Average Long-Term Deferred Tax over 5 years is $10.5 million, with a median of $12.0 million recorded in 2016.
  • Peak YoY movement for Long-Term Deferred Tax: tumbled 72.39% in 2017, then soared 378.57% in 2018.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $6.1 million in 2016, then crashed by 54.07% to $2.8 million in 2017, then skyrocketed by 378.57% to $13.4 million in 2018, then changed by 0.0% to $13.4 million in 2019, then skyrocketed by 31.34% to $17.6 million in 2020.
  • Per Business Quant, the three most recent readings for EBS's Long-Term Deferred Tax are $17.6 million (Q1 2020), $13.4 million (Q4 2019), and $13.4 million (Q4 2018).